患有头癌和低骨肌肉质量的患者如何经历基于西斯的化疗放射治疗? 一个定性研究研究
Anouk W M A Schaeffers1, Maartje A van Beers1, Lot A Devriese2
1Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, G05.122, P.O. Box 85.500, 3508 GA, Utrecht, The Netherlands.
概括
患有头癌和肌肉质量低的患者发现西斯的化学放射治疗令人痛苦. 他们使用支持网络和策略来应对,强调了在这个改变生活的事件中需要量身定制的咨询.
科学领域:
- 在瘤学瘤学.
- 患者体验研究 研究研究
- 质量健康研究 质量健康研究
背景情况:
- 头部和部状细胞癌 (HNSCC) 患者面临重大治疗挑战.
- 基斯普拉丁基化学放射疗法 (CRT) 是有效但有毒的,特别是对于骨肌量 (SMM) 低的患者.
- 患有HNSCC和低SMM的患者面临与治疗相关的困难.
研究的目的:
- 探索HNSCC患者低SMM接受基于的CRT的经验.
- 了解治疗期间和之后面临的身体,情感和心理挑战.
主要方法:
- 采用了一种描述性的定性研究设计.
- 在CRT治疗后三个月,与七名患者进行了半结构面试.
- 使用主题分析来解释患者的体验.
主要成果:
- 前CRT的主题包括信息,期望,心理社会因素和支持系统.
- 在CRT期间,患者经历了毒性,心理社会影响,并依赖支持网络.
- 在CRT后,主题涉及反思,心理社会调整,来自网络和医疗保健工作者的支持,以及持续的毒性.
结论:
- 基于西斯普拉丁的CRT对于大多数HNSCC患者来说是一个令人痛苦的,改变生活的事件.
- 患者使用各种各样的应对策略和支持网络.
- 建议为支持性护理提供量身定制的咨询和按需咨询.
更多相关视频
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
175
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
175
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149